Private Equity
Second Opinion closes out the day with news that Cigna has closed its $54 billion acquisition of Express Scripts, Apple bumps up its AI boss to the executive team and President Trump refuses to sign a bill that will avert the government shutdown unless he gets funding for the border wall.
1 min read · 20 December 2018
Markets have reacted positively and the investor and business community in Brazil is euphoric following Jair Bolsonaro’s electoral win.
3 min read · 20 December 2018
2 min read · 20 December 2018
Abu Dhabi-based Al Jaber Group has agreed restructuring terms for 5.9 billion dirhams ($1.61 billion) in debt, sources told Reuters, potentially ending a long-running dispute with its creditors.
2 min read · 20 December 2018
Senior exec leaves Triton as fundraising comes to a close; H.I.G. to exit Caraustar in $1.8 bln deal; American Renal goes up for sale
2 min read · 20 December 2018
The deal allows Access, a French fund of funds manager, to 'reaffirm its independence' in the face of a wave of consolidation in Europe.
2 min read · 20 December 2018
Private equity firms taking non-control stakes in other such firms is booming, but the off-ramps for such deals remain mostly theoretical.
3 min read · 20 December 2018
First Read begins the day with news that Bristol-Myers gets a $1.6 billion offer for its French consumer health unit, Pinterest is getting ready to go public in early 2019, and Altria Group Inc is nearing a deal to buy more than a third of Juul Labs.
1 min read · 20 December 2018
2 min read · 19 December 2018
In Second Opinion, the Federal Reserve is raising short-term interest rates, Marlboro maker Altria reportedly nears a deal to acquire a minority stake in e-cigarette company Juul and GlaxoSmithKline plans to split into two businesses after forming a new joint venture with Pfizer.
1 min read · 19 December 2018
